Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/249097
COMPARTIR / EXPORTAR:
SHARE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | The endocannabinoid system in mental disorders: Evidence from human brain studies |
Autor: | Ibarra-Lecue, Inés; Pilar-Cuéllar, Fuencisla CSIC ORCID; Muguruza, Carolina; Florensa-Zanuy, Eva CSIC ORCID CVN; Díaz, Álvaro CSIC ORCID; Urigüen, Leyre; Castro, Elena CSIC ORCID; Pazos, Ángel CSIC ORCID; Callado, Luis F. | Palabras clave: | Human brain Depression Anxiety Schizophrenia Endocannabinoids Cannabinoid receptors |
Fecha de publicación: | nov-2018 | Editor: | Elsevier | Citación: | Biochemical Pharmacology 157: 97-107 (2018) | Resumen: | Mental disorders have a high prevalence compared with many other health conditions and are the leading cause of disability worldwide. Several studies performed in the last years support the involvement of the endocannabinoid system in the etiopathogenesis of different mental disorders. The present review will summarize the latest information on the role of the endocannabinoid system in psychiatric disorders, specifically depression, anxiety, and schizophrenia. We will focus on the findings from human brain studies regarding alterations in endocannabinoid levels, cannabinoid receptors and endocannabinoid metabolizing enzymes in patients suffering mental disorders. Studies carried out in humans have consistently demonstrated that the endocannabinoid system is fundamental for emotional homeostasis and cognitive function. Thus, deregulation of the different elements that are part of the endocannabinoid system may contribute to the pathophysiology of several mental disorders. However, the results reported are controversial. In this sense, different alterations in gene and/or protein expression of CB1 receptors have been shown depending on the technical approach used or the brain region studied. Despite the current discrepancies regarding cannabinoid receptors changes in depression and schizophrenia, present findings point to the endocannabinoid system as a pivotal neuromodulatory pathway relevant in the pathophysiology of mental disorders. | Versión del editor: | http://dx.doi.org/10.1016/j.bcp.2018.07.009 | URI: | http://hdl.handle.net/10261/249097 | DOI: | 10.1016/j.bcp.2018.07.009 | Identificadores: | doi: 10.1016/j.bcp.2018.07.009 issn: 0006-2952 |
Aparece en las colecciones: | (IBBTEC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Endocannabinoid_Postprint_Art2018.pdf | 519 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
Page view(s)
57
checked on 22-abr-2024
Download(s)
349
checked on 22-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Este item está licenciado bajo una Licencia Creative Commons